Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-01-23

Clinical Trial Update: Tomotherapy for Refractory Brain Metastases [NA]

View source ↗

Summary

This clinical trial update discusses using Tomotherapy to treat refractory brain metastases. The current status of the trial is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Brain Metastases | NA | Status: UNKNOWN